发明名称 Assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease
摘要 An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. Also provided is an in vitro assay for determining the effect of an activated CD8+ T-cell on a sensitized melanoma cell. A method for improving the specific cytolytic activity (SCA) of an immune cell comprising contacting an immune cell with an antigen and an antigen-independent pro-inflammatory agent is provided. A method for ex vivo expansion of antigen-specific CD8+ T-cells with enhanced specific cytolytic activity (SCA) comprising culturing the antigen-specific CD8+ T-cells in a suitable culture media comprising an amino acid. An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. A method of treating a subject suffering from an infectious or neoplastic disease with immuno therapy is described.
申请公布号 US9488644(B2) 申请公布日期 2016.11.08
申请号 US201013509405 申请日期 2010.11.11
申请人 The Trustees of Columbia University in the City of New York 发明人 Silverstein Samuel C.;Loike John D.;Budhu Sadna;Lee Peter P.
分类号 C12Q1/02;G01N33/50;A61K35/17;A61K38/20;A61K45/06 主分类号 C12Q1/02
代理机构 Bryan Cave LLP 代理人 Bryan Cave LLP
主权项 1. An in vitro assay for determining the effect of an immune cell on a cell from an infectious or neoplastic disease comprising: (a) providing a gel comprising: (i) collagen and fibrin, which gel is sufficient to support viability of an immune cell and growth of a cell from an infectious or neoplastic disease and(ii) an immune cell and a cell from an infectious or neoplastic disease disposed within the gel; (b) incubating the gel under conditions that support viability of the immune cell and growth of the cell from the infectious or neoplastic disease for a period of time sufficient to determine whether the immune cell has an effect on the cell from the infectious or neoplastic disease; (c) determining the number of viable cells from the infectious or neoplastic disease, if any, that are present after step (b),wherein the determining step comprises carrying out a clonogenic assay to determine how many, if any, cells from the infectious or neoplastic disease are present.
地址 New York NY US